NCT05167474

Brief Summary

ABSTRACT Purpose: This research was done for the purpose of determining the impact of breast milk smell administered to term infants hospitalized in neonatal intensive care units (NICU) due to physiological jaundice on their bilirubin levels, length of remaining in phototherapy and comfort. Material and Method: It is an experimental, randomisation, controlled research. Target population of the research consisted of a total of 72 term infants who were hospitalized in the NICU of Bilecik Bozuyuk Public Hospital and met the sample selection criteria. Our research includes two groups. Breast milk smell group and control group. The infants were assigned to the groups via randomization method. Sample assignment to the groups was performed using stratification and blocking methods. The infants meeting the research sample selection criteria were stratified according to their postnatal age and then assigned to each group equally (blocking) by lot. However, two infants in the control group were excluded from the research at the request of their parents as the research continued. Thus, the research was completed with a total of 72 infants; 37 in the breast milk smell group and 35 in the control group. In the research, the data were collected using "Personal Data Collection Form", "Phototherapy Follow-up Chart" and "Neonatal Comfort Behavior Scale". The data were analyzed using the SPSS (Statistical Package for Social Sciences) 21.0 (IBM corp. Relased 2012. IBM SPSS Statistics for Windows, version 21.0 Armonk, NY: IBM corp.) package software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2019

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

November 10, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 22, 2021

Completed
Last Updated

December 22, 2021

Status Verified

December 1, 2021

Enrollment Period

8 months

First QC Date

November 10, 2021

Last Update Submit

December 9, 2021

Conditions

Keywords

newbornphototherapybreast milk smell

Outcome Measures

Primary Outcomes (2)

  • To evaluate the effect of breast milk odor on phototherapy duration during phototherapy treatment.

    While newborns received phototherapy treatment, cotton wool moistened with breast milk in a container was placed near the newborn's nose.

    Upon completion of the study, an average of 3 days

  • To evaluate the bilirubin level of breast milk odor during phototherapy treatment

    While newborns received phototherapy treatment, cotton wool moistened with breast milk in a container was placed near the newborn's nose.

    Upon completion of the study, an average of 3 days

Study Arms (2)

breast milk smell

ACTIVE COMPARATOR

The application of maternal education for the phototherapy method for newborns is to place the cotton unloaded by the mother in a container and place it close to the shape.

Other: breast milk smell

control group

NO INTERVENTION

No intervention was performed during phototherapy treatment in newborns.

Interventions

yenidoğanlara fototerapi tedavisi esnasında anne sütü kokusu uygulanmıştır.

Also known as: kontrol grubu
breast milk smell

Eligibility Criteria

Age2 Days - 5 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The term baby (37-39+6 weeks) of the newborn according to the menstruation of the mothers
  • Need to have phototherapy treatment for the first time
  • Not taking analgesics and/or sedatives in the last 24 hours
  • Body weight in the range of 2500 - 4000 g
  • Postnatal age of the newborn greater than 48 hours
  • Turkish Neonatology Society's approach, follow-up and treatment guideline for neonatal jaundice (2014) Being a medium and high risk baby according to the table of risk status determination of babies according to postnatal age and transcutaneous or total serum bilirubin values.
  • Not taking any treatment or medication other than phototherapy treatment
  • The mother and/or father accepting the study is having a baby.

You may not qualify if:

  • Having a health problem other than physiological jaundice
  • Findings such as tachypnea, fever
  • Having an invasive procedure other than blood sampling once a day for babies
  • Exchanged babies
  • Babies with Rh and AB0 incompatibility
  • Babies with elevated bilirubin levels earlier than 48 hours
  • Discord with family

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eskisehir Osmangazi University

Eskişehir, Odunpazarı, 26000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Jaundice, Neonatal

Condition Hierarchy (Ancestors)

Hyperbilirubinemia, NeonatalInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
nurse

Study Record Dates

First Submitted

November 10, 2021

First Posted

December 22, 2021

Study Start

August 1, 2018

Primary Completion

April 10, 2019

Study Completion

April 10, 2019

Last Updated

December 22, 2021

Record last verified: 2021-12

Locations